Immunomodulation by IAP inhibitors

Details for Australian Patent Application No. 2009246347 (hide)

Owner Novartis AG Dana Farber Cancer Institute, Inc.

Inventors Zawel, Leigh

Agent Davies Collison Cave

Pub. Number AU-A-2009246347

PCT Pub. Number WO2009/140447

Priority 61/053,947 16.05.08 US

Filing date 14 May 2009

Wipo publication date 19 November 2009

International Classifications

A61K 31/437 (2006.01)

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/140447 Priority application(s): WO2009/140447

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009246348-Tetrahydrocyclopenta[b]indole androgen receptor modulators

2009246344-System and method for distributing coupon content and transactional advertisements